Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Nov;65(11):4502–4508. doi: 10.1128/iai.65.11.4502-4508.1997

Role of outer membrane protein H (OmpH)- and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida.

M Vasfi Marandi 1, K R Mittal 1
PMCID: PMC175647  PMID: 9353026

Abstract

Two major outer membrane proteins of Pasteurella multocida, designated OmpH and OmpA, were characterized and shown to be related to the families of porin and heat-modifiable proteins, respectively. The backpack hybridoma tumor system in BALB/c mice was used to continuously deliver immunoglobulin G2b (IgG2b) monoclonal antibodies (MAbs) specific for OmpH (MAb MT1) and OmpA (MAb MT4.1). MAbs were detected in serum and peritoneal lavage samples of mice bearing hybridoma tumors by an enzyme-linked immunosorbent assay and an immunoblot assay. Highly significant protection was observed in mice bearing MT1 hybridoma tumors against both intraperitoneal and intranasal challenge infections with homologous nontoxigenic P. multocida strains possessing MAb MT1-reacting epitopes, whereas the mice bearing MT4.1 hybridoma tumors were not protected. The numbers of P. multocida organisms in the lungs of mice bearing MT1 hybridoma tumors were significantly less than those in lungs of mice bearing MT4.1 hybridoma tumors at 48 h postchallenge. These results indicate that the OmpH-specific MAb inhibited proliferation of P. multocida in the lungs. MAb MT1 was unable to kill P. multocida in vitro in the presence of complement. However, an enhanced phagocytosis by polymorphonuclear cells (PMNs) was observed in mice bearing MT1 hybridoma tumors. P. multocida induced a more extensive and rapid influx of PMNs into the peritoneal cavity of mice bearing MT1 hybridoma tumors than of mice bearing MT4.1 hybridoma tumors. The results of this study demonstrate for the first time that IgG MAbs against OmpH of P. multocida are involved in the protection of mice against lethal challenge infection by means of opsonization and inhibition of proliferation of P. multocida as a result of increased influx of PMNs into the infection site.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashfaq M. K., Campbell S. G. The influence of opsonins on the bactericidal effect of bovine alveolar macrophages against Pasteurella multocida. Cornell Vet. 1986 Apr;76(2):213–221. [PubMed] [Google Scholar]
  2. Bierer B. W., Derieux W. T. Immunologic response of turkeys to an avirulent Pasteurella multocida vaccine in the drinking water. Poult Sci. 1972 Mar;51(2):408–416. doi: 10.3382/ps.0510408. [DOI] [PubMed] [Google Scholar]
  3. Bording A., Nymark K., Smidt E. Field trials with a new genetically engineered vaccine for protection against progressive atrophic rhinitis in pigs. Acta Vet Scand. 1994;35(2):155–163. doi: 10.1186/BF03548343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carter G. R. Pasteurellosis: Pasteurella multocida and Pasteurella hemolytica. Adv Vet Sci. 1967;11:321–379. [PubMed] [Google Scholar]
  5. Chanter N., Rutter J. M., Mackenzie A. Partial purification of an osteolytic toxin from Pasteurella multocida. J Gen Microbiol. 1986 Apr;132(4):1089–1097. doi: 10.1099/00221287-132-4-1089. [DOI] [PubMed] [Google Scholar]
  6. Chevalier G., Duclohier H., Thomas D., Shechter E., Wróblewski H. Purification and characterization of protein H, the major porin of Pasteurella multocida. J Bacteriol. 1993 Jan;175(1):266–276. doi: 10.1128/jb.175.1.266-276.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clark R. A. The human neutrophil respiratory burst oxidase. J Infect Dis. 1990 Jun;161(6):1140–1147. doi: 10.1093/infdis/161.6.1140. [DOI] [PubMed] [Google Scholar]
  8. Collins F. M., Woolcock Immune responses to Pasteurella multocida in the mouse. J Reticuloendothel Soc. 1976 May;19(5):311–321. [PubMed] [Google Scholar]
  9. Dua S. K., Maheswaran S. K. Studies on Pasteurella multocida. VI. Nature of systemic immunity and analysis of the correlation between levels of immunity induced by various fowl cholera vaccines and protection against challenge. Avian Dis. 1978 Oct-Dec;22(4):748–764. [PubMed] [Google Scholar]
  10. Fulton R. M., Reed W. M., DeNicola D. B. Light microscopic and ultrastructural characterization of cells recovered by respiratory-tract lavage of 2- and 6-week-old chickens. Avian Dis. 1990 Jan-Mar;34(1):87–98. [PubMed] [Google Scholar]
  11. Gilleland L. B., Gilleland H. E., Jr Synthetic peptides representing two protective, linear B-cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole-cell-reactive antibodies that are functionally pseudomonad specific. Infect Immun. 1995 Jun;63(6):2347–2351. doi: 10.1128/iai.63.6.2347-2351.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harmon B. G., Glisson J. R., Latimer K. S., Steffens W. L., Nunnally J. C. Resistance of Pasteurella multocida A:3,4 to phagocytosis by turkey macrophages and heterophils. Am J Vet Res. 1991 Sep;52(9):1507–1511. [PubMed] [Google Scholar]
  13. Harmon B. G., Glisson J. R., Nunnally J. C. Turkey macrophage and heterophil bactericidal activity against Pasteurella multocida. Avian Dis. 1992 Oct-Dec;36(4):986–991. [PubMed] [Google Scholar]
  14. Hofacre C. L., Glisson J. R., Kleven S. H., Brown J., Rowland G. N. Evaluation of Pasteurella multocida mutants of low virulence. I. Development and pathogenicity. Avian Dis. 1989 Apr-Jun;33(2):270–274. [PubMed] [Google Scholar]
  15. Isibasi A., Ortiz-Navarrete V., Paniagua J., Pelayo R., González C. R., García J. A., Kumate J. Active protection of mice against Salmonella typhi by immunization with strain-specific porins. Vaccine. 1992;10(12):811–813. doi: 10.1016/0264-410x(92)90041-h. [DOI] [PubMed] [Google Scholar]
  16. Jacques M., Bélanger M., Diarra M. S., Dargis M., Malouin F. Modulation of Pasteurella multocida capsular polysaccharide during growth under iron-restricted conditions and in vivo. Microbiology. 1994 Feb;140(Pt 2):263–270. doi: 10.1099/13500872-140-2-263. [DOI] [PubMed] [Google Scholar]
  17. Kasten R. W., Hansen L. M., Hinojoza J., Bieber D., Ruehl W. W., Hirsh D. C. Pasteurella multocida produces a protein with homology to the P6 outer membrane protein of Haemophilus influenzae. Infect Immun. 1995 Mar;63(3):989–993. doi: 10.1128/iai.63.3.989-993.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lemcke R. M., Burrows M. R. A disc growth-inhibition test for differentiating Treponema hyodysenteriae from other intestinal spirochaetes. Vet Rec. 1979 Jun 16;104(24):548–551. doi: 10.1136/vr.104.24.548. [DOI] [PubMed] [Google Scholar]
  19. Lu Y. S., Afendis S. J., Pakes S. P. Identification of immunogenic outer membrane proteins of Pasteurella multocida 3:A in rabbits. Infect Immun. 1988 Jun;56(6):1532–1537. doi: 10.1128/iai.56.6.1532-1537.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lu Y. S., Gerrity L. W., Afendis S. J., Watkins L., Pakes S. P. Distribution of a monoclonal antibody-recognized protective protein immunogen on the outer membranes of Pasteurella multocida rabbit isolates. J Clin Microbiol. 1988 Jul;26(7):1326–1330. doi: 10.1128/jcm.26.7.1326-1330.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lu Y. S., Lai W. C., Pakes S. P., Nie L. C. A monoclonal antibody against a Pasteurella multocida outer membrane protein protects rabbits and mice against pasteurellosis. Infect Immun. 1991 Jan;59(1):172–180. doi: 10.1128/iai.59.1.172-180.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lu Y. S., Lai W. C., Pakes S. P., Stefanu C. The outer membrane of Pasteurella multocida 3:A protects rabbits against homologous challenge. Infect Immun. 1991 Dec;59(12):4517–4523. doi: 10.1128/iai.59.12.4517-4523.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lübke A., Hartmann L., Schröder W., Hellmann E. Isolation and partial characterization of the major protein of the outer membrane of Pasteurella haemolytica and Pasteurella multocida. Zentralbl Bakteriol. 1994 Jun;281(1):45–54. doi: 10.1016/s0934-8840(11)80636-5. [DOI] [PubMed] [Google Scholar]
  24. Marandi M. V., Mittal K. R. Identification and characterization of outer membrane proteins of Pasteurella multocida serotype D by using monoclonal antibodies. J Clin Microbiol. 1995 Apr;33(4):952–957. doi: 10.1128/jcm.33.4.952-957.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Marandi M., Mittal K. R. Characterization of an outer membrane protein of Pasteurella multocida belonging to the OmpA family. Vet Microbiol. 1996 Dec;53(3-4):303–314. doi: 10.1016/s0378-1135(96)01219-9. [DOI] [PubMed] [Google Scholar]
  26. Mittal K. R., Ingram D. G. Factors involved in bactericidal activity of sheep serum. Am J Vet Res. 1975 Aug;36(08):1183–1187. [PubMed] [Google Scholar]
  27. Ramdani, Adler B. Opsonic monoclonal antibodies against lipopolysaccharide (LPS) antigens of Pasteurella multocida and the role of LPS in immunity. Vet Microbiol. 1991 Feb 15;26(4):335–347. doi: 10.1016/0378-1135(91)90027-d. [DOI] [PubMed] [Google Scholar]
  28. Rebers P. A., Heddleston K. L., Wright B., Gillette K. Fowl cholera; cross-protective turkey antisera and IgG antibodies induced with Pasteurella multocida-infected tissue bacterins. Carbohydr Res. 1975 Mar;40(1):99–110. doi: 10.1016/s0008-6215(00)82672-5. [DOI] [PubMed] [Google Scholar]
  29. Rhoades K. R., Rimler R. B. Capsular groups of Pasteurella multocida isolated from avian hosts. Avian Dis. 1987 Oct-Dec;31(4):895–898. [PubMed] [Google Scholar]
  30. Rimler R. B. Partial purification of cross-protection factor(s) from Pasteurella multocida. Avian Dis. 1994 Oct-Dec;38(4):778–789. [PubMed] [Google Scholar]
  31. Rimler R. B., Rhoades K. R. Serogroup F, a new capsule serogroup of Pasteurella multocida. J Clin Microbiol. 1987 Apr;25(4):615–618. doi: 10.1128/jcm.25.4.615-618.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ruffolo C. G., Adler B. Cloning, sequencing, expression, and protective capacity of the oma87 gene encoding the Pasteurella multocida 87-kilodalton outer membrane antigen. Infect Immun. 1996 Aug;64(8):3161–3167. doi: 10.1128/iai.64.8.3161-3167.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Smith R. H., Babiuk L. A., Stockdale P. H. Intranasal immunization of mice against Pasteurella multocida. Infect Immun. 1981 Jan;31(1):129–135. doi: 10.1128/iai.31.1.129-135.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Snipes K. P., Hirsh D. C., Kasten R. W., Carpenter T. E., Hird D. W., McCapes R. H. Differentiation of field isolates of Pasteurella multocida serotype 3,4 from live vaccine strain by genotypic characterization. Avian Dis. 1990 Apr-Jun;34(2):419–424. [PubMed] [Google Scholar]
  35. Toth T. E., Siegel P. B. Cellular defense of the avian respiratory tract: paucity of free-residing macrophages in the normal chicken. Avian Dis. 1986 Jan-Mar;30(1):67–75. [PubMed] [Google Scholar]
  36. Truscott W. M., Hirsh D. C. Demonstration of an outer membrane protein with antiphagocytic activity from Pasteurella multocida of avian origin. Infect Immun. 1988 Jun;56(6):1538–1544. doi: 10.1128/iai.56.6.1538-1544.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vasfi Marandi M., Dubreuil J. D., Mittal K. R. The 32 kDa major outer-membrane protein of Pasteurella multocida capsular serotype D. Microbiology. 1996 Jan;142(Pt 1):199–206. doi: 10.1099/13500872-142-1-199. [DOI] [PubMed] [Google Scholar]
  38. Wang C., Glisson J. R. Identification of common antigens of serotype 1 and serotype 3 Pasteurella multocida in poultry expressed in vivo. Avian Dis. 1994 Apr-Jun;38(2):334–340. [PubMed] [Google Scholar]
  39. Wang C., Glisson J. R. Passive cross-protection provided by antisera directed against in-vivo-expressed antigens of Pasteurella multocida. Avian Dis. 1994 Jul-Sep;38(3):506–514. [PubMed] [Google Scholar]
  40. Wijewardana T. G., Sutherland A. D. Bactericidal activity in the sera of mice vaccinated with Pasteurella multocida type A. Vet Microbiol. 1990 Jul;24(1):55–62. doi: 10.1016/0378-1135(90)90050-6. [DOI] [PubMed] [Google Scholar]
  41. Wijewardana T. G., Wilson C. F., Gilmour N. J., Poxton I. R. Production of mouse monoclonal antibodies to Pasteurella multocida type A and the immunological properties of a protective anti-lipopolysaccharide antibody. J Med Microbiol. 1990 Dec;33(4):217–222. doi: 10.1099/00222615-33-4-217. [DOI] [PubMed] [Google Scholar]
  42. Winner L., 3rd, Mack J., Weltzin R., Mekalanos J. J., Kraehenbuhl J. P., Neutra M. R. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun. 1991 Mar;59(3):977–982. doi: 10.1128/iai.59.3.977-982.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Woolcock J. B., Collins F. M. Immune mechanism in Pasteurella multocida-infected mice. Infect Immun. 1976 Mar;13(3):949–958. doi: 10.1128/iai.13.3.949-958.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zhang H., Ainsworth A. J., Montgomery R. D. Use of a 35.5 kDa cell membrane composition of Pasteurella multocida and an anti-idiotype antibody to induce protective immunity in leghorn chickens. Vet Immunol Immunopathol. 1994 May;41(1-2):89–100. doi: 10.1016/0165-2427(94)90059-0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES